India’s pharmaceutical exports are thriving, reaching $28.29 billion in April-February FY26, a 5.6% rise despite global challenges. The sector, currently valued at $60 billion, is projected to hit $130 billion by 2030. Leaders are optimistic about continued growth, even with potential US tariff impacts on future exports.India’s pharmaceutical exports are thriving, reaching $28.29 billion in April-February FY26, a 5.6% rise despite global challenges. The sector, currently valued at $60 billion, is projected to hit $130 billion by 2030. Leaders are optimistic about continued growth, even with potential US tariff impacts on future exports.
